Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: J Autism Dev Disord. 2018 May;48(5):1742–1760. doi: 10.1007/s10803-017-3421-9

Table 1.

Participant Characteristics by Group at Baseline

Variable Control Group Treatment Group All



N Mean/% SD N Mean/% SD N Mean/% SD
Age 16 25.5 7.1 25 24.9 6.1 41 25.1 6.4
Full-Scale IQ 16 102.8 14.4 25 101.4 19.4 41 102.0 17.4
Female 4 25.0 N/A 9 36.0 N/A 13 31.7 N/A
Caucasian 10 62.5 N/A 20 80.0 N/A 30 73.2 N/A
Living Independently 5 31.3 N/A 6 24.0 N/A 11 26.8 N/A
ADOS SA Total 16 10.9 3.1 25 9.2 3.1 41 9.9 3.2
ADOS RRB Total 16 3.1 2.2 25 3.0 1.3 41 3.0 1.7
ADOS Total 16 14.0 3.9 25 12.2 3.2 41 12.9 3.6
ADOS CSS 16 7.4 1.6 25 6.7 1.9 41 7.0 1.8
Medication 8 50.0 N/A 14 56.0 N/A 22 53.7 N/A
Therapy 12 75.0 N/A 17 68.0 N/A 29 70.7 N/A
Anxiety Disorder 3 18.8 N/A 3 12.0 N/A 6 14.6 N/A
Borderline Anxiety Levels 2 12.5 N/A 3 12.0 N/A 5 12.2 N/A
Clinical Anxiety Levels 1 6.3 N/A 1 4.0 N/A 2 4.9 N/A

Note. ADOS = Autism Diagnostic Observation Schedule 2. SA = Social Affect. RRB = Restricted and Repetitive Behaviors. CSS = Calibrated Severity Score based on revised ADOS algorithm. Medication = Participants on psychiatric or sleep medications. Therapy = Participants receiving individual therapy services. Anxiety Disorder = Medical diagnosis of Generalized Anxiety Disorder or Social Anxiety Disorder per Social Coach report. Borderline Anxiety Levels = Participant self-reported borderline levels of anxiety based on ASR Anxiety Problems Scale. Clinical Anxiety Levels = Participant self-reported clinical levels of anxiety based on ASR Anxiety Problems Scale.